ATYR — aTyr Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapMomentum Trap

Annual balance sheet for aTyr Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	31.7	108	66.1	98.2	72.1
Net Total Receivables	2.04	0.435	11.8	2.44	1.74
Prepaid Expenses
Total Current Assets	35.5	114	80.9	103	82
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.98	1.81	11.6	14	11.9
Other Long Term Assets
Total Assets	38.7	116	95.8	121	96.8
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	5.86	6.01	13.9	16.4	15
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	7.08	6.24	24.3	30	26.8
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	31.6	109	71.5	90.7	70
Total Liabilities & Shareholders' Equity	38.7	116	95.8	121	96.8
Total Common Shares Outstanding